摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,3-丙烷二基二(2-羟基苯甲酸酯) | 84370-82-1

中文名称
1,3-丙烷二基二(2-羟基苯甲酸酯)
中文别名
——
英文名称
1,3-bis-salicyloyloxy-propane
英文别名
1,3-Bis-salicyloyloxy-propan;1.3-Disalicyloyloxy-propan;1,3-propanediyl disalicylate;1,3-propanediyl bissalicylate;3-(2-hydroxybenzoyl)oxypropyl 2-hydroxybenzoate
1,3-丙烷二基二(2-羟基苯甲酸酯)化学式
CAS
84370-82-1
化学式
C17H16O6
mdl
——
分子量
316.31
InChiKey
RXRCNOIPYFJQPE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    77 °C
  • 沸点:
    466.4±30.0 °C(Predicted)
  • 密度:
    1.320±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.7
  • 重原子数:
    23
  • 可旋转键数:
    8
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    93.1
  • 氢给体数:
    2
  • 氢受体数:
    6

SDS

SDS:5ea47ca65bbe16315652c1bf4172da92
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    1,3-二溴丙烷水杨酸三乙胺 作用下, 以 DMF (N,N-dimethyl-formamide) 为溶剂, 反应 24.33h, 以85%的产率得到1,3-丙烷二基二(2-羟基苯甲酸酯)
    参考文献:
    名称:
    High molecular wegiht polymers, devices and method for making and using same
    摘要:
    无水酐聚合物释放活性或可激活的药剂,具有预选特性,如分子量、柔韧性、硬度、粘附性等其他有价值的特性。这些聚合物适用于在一段时间内控制释放药剂的组合物、配方、涂层、设备等,这些产品受益于药剂的控制释放。这些聚合物是通过涉及各种替代和连续步骤的过程制备的,这些步骤允许事先设计具有特定特性的产品。这些聚合物适合作为传递系统,可以单独使用,也可以作为组合物、配方或设备。
    公开号:
    US20050048121A1
点击查看最新优质反应信息

文献信息

  • Compositions and methods for the inhibition of bone growth and resorption
    申请人:Uhrich E. Kathryn
    公开号:US20050249697A1
    公开(公告)日:2005-11-10
    A composition, or article for inhibition of bone growth and resorption comprises an anti-inflammatory agent(s), optionally other agents and carriers, monomer(s), oligomer(s), polymer(s), salt(s), mixtures(s), dispersion(s) and/or blend(s) thereof, which composition, device, or implant upon polymer erosion releases a bone growth and/or bone resorption retarding, reducing or inhibiting amount of the agent(s). The monomers, oligomers and polymers, releasing active or activatable agent(s), have pre-selected properties such as molecular weight, flexibility, hardness, adhesiveness, and other valuable properties. The monomers, oligomers and polymers may be prepared by a process involving various alternative and sequential steps that allow the design a priori of products with specific characteristics. The composition, device, implant or dressing of this patent are suitable for retarding, reducing or inhibiting bone growth or bone resorption, comprising administering or applying to a subject's pre-selected site a bone growth or resorption reducing amount of the agent(s).
    一种用于抑制骨生长和吸收的组合物或文章包括抗炎剂、可选的其他剂和载体、单体、寡聚体、聚合物、盐、混合物、分散剂和/或其混合物,该组合物、装置或植入物在聚合物侵蚀时释放出抑制、减少或抑制骨生长和/或骨吸收的剂量的药物。释放活性或可激活药物的单体、寡聚体和聚合物具有预选的性质,如分子量、柔韧性、硬度、粘附性和其他有价值的性质。可以通过涉及各种可选和连续步骤的过程来制备单体、寡聚体和聚合物,从而允许事先设计具有特定特性的产品。该专利的组合物、装置、植入物或敷料适用于减缓、减少或抑制骨生长或骨吸收,包括向受试者的预选部位施用或应用抑制骨生长或吸收的药物。
  • HIGH MOLECULAR WEIGHT POLYMERS, DEVICES AND METHOD FOR MAKING AND USING SAME
    申请人:East Anthony
    公开号:US20100152410A1
    公开(公告)日:2010-06-17
    Anhydride polymers that release active or activatable agent(s) have pre-selected properties such as molecular weight, flexibility, hardness, adhesiveness, and other valuable properties. The polymers are suitable for use in compositions, formulations, coatings, devices, and the like that benefit from the controlled release of an agent(s) over a period of time. The polymers are prepared by a process involving various alternative and sequential steps that allow the design a priori of products with specific characteristics. The polymers are suitable as delivery systems, either by themselves, as compositions, formulations or devices.
    无水酐聚合物可以释放活性或可激活的药剂,具有预选的性质,如分子量、柔韧性、硬度、粘附性和其他有价值的性质。这些聚合物适用于需要在一段时间内控制释放药剂的组合物、配方、涂层、装置等。这些聚合物是通过涉及各种替代和顺序步骤的过程制备的,允许事先设计具有特定特性的产品。这些聚合物适用于作为传递系统,可以作为组合物、配方或装置本身。
  • High molecular weight polymers, devices and method for making and using same
    申请人:Rutgers, The State University of New Jersey
    公开号:US08232322B2
    公开(公告)日:2012-07-31
    Anhydride polymers that release active or activatable agent(s) have pre-selected properties such as molecular weight, flexibility, hardness, adhesiveness, and other valuable properties. The polymers are suitable for use in compositions, formulations, coatings, devices, and the like that benefit from the controlled release of an agent(s) over a period of time. The polymers are prepared by a process involving various alternative and sequential steps that allow the design a priori of products with specific characteristics. The polymers are suitable as delivery systems, either by themselves, as compositions, formulations or devices.
    无水酐聚合物可以释放活性或可活化剂,具有预先选择的分子量、柔韧性、硬度、粘附性和其他有价值的特性。这些聚合物适用于需要在一段时间内控制释放剂量的组成物、配方、涂层、设备等。该聚合物是通过涉及各种替代和顺序步骤的过程制备的,这些步骤允许事先设计具有特定特性的产品。该聚合物适用于作为传递系统,可以作为组成物、配方或设备本身。
  • Solution polymerization processes to prepare a polymer that degrades to release a physiologically active agent
    申请人:Rutgers, The State University of New Jersey
    公开号:US07662864B2
    公开(公告)日:2010-02-16
    Anhydride polymers that release active or activatable agent(s) have pre-selected properties such as molecular weight, flexibility, hardness, adhesiveness, and other valuable properties. The polymers are suitable for use in compositions, formulations, coatings, devices, and the like that benefit from the controlled release of an agent(s) over a period of time. The polymers are prepared by a process involving various alternative and sequential steps that allow the design a priori of products with specific characteristics. The polymers are suitable as delivery systems, either by themselves, as compositions, formulations or devices.
    无水酐聚合物可以释放活性或可激活的剂量,具有预选的性质,如分子量、柔韧性、硬度、粘附性和其他有价值的特性。这些聚合物适用于需要在一定时间内控制释放剂量的组合物、配方、涂层、装置等。聚合物是通过涉及各种替代和顺序步骤的过程制备的,允许事先设计具有特定特性的产品。这些聚合物适用于作为输送系统,可以单独使用,也可以作为组合物、配方或装置。
  • Synthesis and in vitro evaluation of triphenylphosphonium derivatives of acetylsalicylic and salicylic acids: structure-dependent interactions with cancer cells, bacteria, and mitochondria
    作者:Olga V. Tsepaeva、Taliya I. Salikhova、Leysan R. Grigor’eva、Denis V. Ponomaryov、Trinh Dang、Rezeda A. Ishkaeva、Timur I. Abdullin、Andrey V. Nemtarev、Vladimir F. Mironov
    DOI:10.1007/s00044-020-02674-6
    日期:2021.4
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐